Inhibiting oocyte postovulatory aging is important both for healthy reproduction and for assisted reproduction techniques. Some studies suggest that glucose promotes oocyte meiotic resumption through glycolysis, but others indicate that it does so by means of the pentose phosphate pathway (PPP). Furthermore, although pyruvate was found to prevent oocyte aging, the mechanism is unclear. The present study addressed these issues by using the postovulatory aging oocyte model. The results showed that whereas the oocyte itself could utilize pyruvate or lactate to prevent aging, it could not use glucose unless in the presence of cumulus cells. Glucose metabolism in cumulus cells prevented oocyte aging by producing pyruvate and NADPH through glycolysis and PPP. Whereas PPP was still functioning after inhibition of glycolysis, the glycolysis was completely inactivated after inhibition of PPP. Addition of fructose-6-phosphate, an intermediate product from PPP, alleviated oocyte aging significantly when the PPP was totally inhibited. Lactate prevented oocyte aging through its lactate dehydrogenasecatalyzed oxidation to pyruvate, but pyruvate inhibited oocyte aging by its intramitochondrial metabolism. However, both lactate and pyruvate required mitochondrial electron transport to prevent oocyte aging. The inhibition of oocyte aging by both PPP and pyruvate involved regulation of the intracellular redox status. Together, the results suggest that glucose metabolism in cumulus cells prevented oocyte postovulatory aging by maintaining both energy supply and the intracellular redox potential and that) glycolysis in cumulus cells might be defective, with pyruvate production depending upon the PPP for intermediate products.
INTRODUCTION
Mammalian oocytes can undergo postovulatory aging when ovulated oocytes are retained in the oviduct for a relatively long period. Oocyte aging after ovulation significantly affects embryo development [1] [2] [3] [4] . In vivo fertilization of aged oocytes gives rise to mice suffering from nervous and emotional abnormalities [5] as well as decreased reproductive fitness and longevity [6] . Like detention in the oviduct, in vitro culture of matured oocytes also leads to oocyte aging [7] [8] [9] . Humans and some animals potentially undertake sexual activity on any day of the estrous cycle, which may cause fertilization of aged oocytes. Many experimental designs in both research and clinical applications involve culture of matured oocytes before micromanipulation or insemination. For example, the cell-cycle stage of the recipient cytoplasts must be finely controlled for the success of nuclear transfer for cloning [10, 11] ; rates of cell fusion and embryonic development of nuclear transfer embryos decreased significantly when aged oocytes were used for recipient cytoplasts [12, 13] . Therefore, studies on the mechanisms and control of oocyte postovulatory aging are important for the healthy reproduction of both humans and nonhuman mammals.
Studies have shown that subtle changes in the energy substrate composition of the culture medium can have profound effects on meiotic maturation of mammalian oocytes. For example, the meiosis-inducing action of follicle-stimulating hormone (FSH) on cumulus-oocyte complexes (COCs) was eliminated when glucose was removed from the culture medium [14] . Millimolar concentrations of pyruvate reversed the meiotic arrest mediated by hypoxanthine or dibutyryl cAMP in the absence of glucose [14, 15] . In addition, FSH treatment increased hexokinase activity of the COCs and greatly augmented glucose metabolism through the glycolytic pathway [16] . Although this suggests that the positive effect of glucose is mediated by glycolytic production of pyruvate, which can then be oxidized to generate the energy necessary for nuclear maturation, other data indicate that the glucose requirement for meiotic induction does not depend on its glycolysis to pyruvate. For example, the 2-deoxyglucose block to glycolysis was not necessarily associated with suppression of FSH-induced meiotic maturation in hypoxanthine-arrested oocytes [16] . Iodoacetate inhibition of glycolysis did not impair LH-induced resumption of oocyte meiosis [17] . Furthermore, pyruvate alone was unable to increase ATP production in COCs [18] , and COCs did not show increased oxygen consumption when exposed to pyruvate or gonadotropin stimulation [19] [20] [21] [22] .
Based on their finding that purine nucleotide-generating pathways participated in gonadotropin stimulation of meiotic maturation [23] , Downs et al. [24] proposed that the pentose phosphate pathway (PPP) was the alternative pathway to glycolysis that mediated the positive action of glucose, because the PPP can provide ribose-5-phosphate for synthesis of phosphoribosyl pyrophosphate (PRPP), an important substrate for the purine nucleotide-generating pathways. Those authors tested this hypothesis and concluded that glucose metabolism through the PPP was involved in the meiotic induction through the generation of PRPP [24] . However, they were unable to observe a rise in PRPP following activation of the PPP with phenazine ethosulfate or pyrroline-5-carboxylate. Furthermore, they used hypoxanthine to arrest meiotic maturation, and the addition of hypoxanthine was found to lower the level of PRPP in the same study. Therefore, the role of PPP in the glucose regulation of oocyte function must be studied using a system not including hypoxanthine.
Our recent studies indicated that cumulus cells accelerated, but pyruvate prevented, postovulatory aging of mouse oocytes [25] [26] [27] . However, the mechanisms by which cumulus cells, and pyruvate in particular, regulate oocyte aging are unknown. Furthermore, because oxidative stress has been shown to cause an imbalance of the intracellular redox potential [28] , leading to apoptosis of the early embryo [29, 30] and postovulatory aging of the egg [4, 31, 32] , it is important to understand how intermediary metabolism regulates the oocyte redox potential. In the present study, we examined glucose metabolism using the postovulatory aging mouse oocyte model, with an emphasis on interactions between cumulus cells and the oocyte, between the PPP and glycolysis pathways, between pyruvate and lactate, and between energy supply and redox potential. The results indicate that glucose metabolism in cumulus cells prevent oocyte aging by maintaining both energy supply and the intracellular redox potential and that glycolysis in cumulus cells might be defective, with pyruvate production depending upon the PPP for intermediate products.
MATERIALS AND METHODS
Chemicals and reagents used in the present study were purchased from Sigma Chemical Co. unless otherwise specified.
Oocyte Recovery
Mice of the Kunming breed were kept in a room under a 14L:10D photoperiod, with lights-off at 2000 h. The animals were handled according to the rules stipulated by the Animal Care and Use Committee of Shandong Agricultural University. Female mice (age, 6-8 wk) were induced to superovulate with equine chorionic gonadotropin (eCG; 10 IU i.p.), followed 48 h later by human chorionic gonadotropin (hCG; 10 IU i.p.). Both the eCG and the hCG were from Ningbo Hormone Product Co., Ltd. The superovulated mice were killed 13 h after hCG injection, and the oviductal ampullae were broken to release COCs. After being dispersed and washed three times in M2 medium, some of the COCs were denuded of cumulus cells by pipetting with a thin pipette in a drop of M2 medium containing 0.1% hyaluronidase to prepare cumulus-denuded oocytes (DOs).
In Vitro Aging of Oocytes
For in vitro aging, COCs and DOs were cultured for 6 h in the ChatotZiomek-Bavister (CZB) medium (NaCl, 81.62 mM; KCl, 4.83 mM; KH 2 PO 4 , 1.18 mM; MgSO 4 , 1.18 mM; NaHCO 3 , 25.12 mM; CaCl 2 Á2H 2 0, 1.7 mM; ethylenediaminetetra-acetic acid [EDTA], 0.11 mM; glutamine, 1 mM; bovine serum albumin, 5 g/L; penicillin, 0.06 g/L; streptomycin, 0.05 g/L) supplemented with different concentrations of energy substrates, metabolism regulators, and/or glutathione (GSH) synthesis-promoting substances. The osmotic pressure of the medium was adjusted by increasing the amount of sodium chloride accordingly when sodium lactate was excluded from the medium. To prepare stock solutions, dehydroepiandrosterone (DHEA; 200 mM), a-cyano-4-hydroxy cinnamate (4-CIN; 100 mM), and rotenone (1 mM) were dissolved in dimethyl sulfoxide; iodoacetate (4 mM) was dissolved in water; cysteamine (50 mM) was dissolved in PBS; and cystine (50 mM) was first dissolved in 1 N HCl and then diluted with water. All the stock solutions were stored in aliquots at À208C and diluted to desired concentrations with the aging medium immediately before use. Oxamate was dissolved in aging medium directly before use.
The culture was conducted in wells (20-25 oocytes/well) of a 96-well culture plate containing 200 ll of medium, covered with mineral oil, at 378C under 5% CO 2 in humidified air. At the end of in vitro aging, the oocytes were allocated to parthenogenetic activation or assays for intracellular GSH concentrations.
Oocyte Activation
Before treatment, COCs were denuded of cumulus cells by pipetting in M2 medium containing 0.1% hyaluronidase. Oocytes were first treated with 5% (v/ v) ethanol in M2 medium for 5 min at room temperature, then washed three times and cultured in the regular CZB medium (with 0.27 mM pyruvate but no glucose) containing 2 mM 6-dimethylaminopurine (6-DMAP) for 6 h. At the end of culture, oocytes were observed under a microscope for activation. Only those oocytes that had one or two pronuclei, or two cells each having a nucleus, were considered to be activated. Oocytes for controls were cultured for 6 h in regular CZB medium containing no 6-DMAP without prior ethanol treatment. Controls were conducted for each experiment, and data were used only when no control oocytes were activated in the experiment.
Assay for Intracellular GSH
Intracellular content of GSH was measured as described by Funahashi et al. [33] . Cumulus-free oocytes were washed three times in M2 medium. Five microliters of distilled water containing 35-40 oocytes was transferred to a 1.5-ml microfuge tube, and then 5 ll of 1.25 M phosphoric acid were added to the tube. Samples were frozen at À808C and thawed at room temperature. This procedure was repeated three times. Next, the samples were stored at À208C until analyzed. Concentrations of total GSH (GSX) in the oocyte were determined by the 5,5
0 -dithio-bis(2-nitrobenzoic acid) (DTNB)-oxidized GSH (GSSG) reductase-recycling assay. Briefly, 700 ll of 0.33 mg/ml of NADPH in 0.2 M sodium phosphate buffer containing 10 mM EDTA (stock buffer, pH 7.2), 100 ll of 6 mM DTNB in the stock buffer, and 190 ll of distilled water were added and mixed in a microfuge tube. Ten microliters of GSH reductase (G-3664; 250 IU/ml) were added with mixing to initiate the reaction. The absorbance was monitored continuously at 412 nm with a spectrophotometer for 3 min, with a reading recorded every 0.5 min. To measure the concentrations of GSSG, the samples (10 ll) were vigorously mixed with 0.2 ll of 2-vinylpyridine and 0.6 ll of triethanolamine. After 60 min, the sample was assayed as described above in the DTNB-GSSG reductase-recycling assay. Standards (0.01, 0.02, 0.1, 0.2, and 1.0 mM) of GSX and a sample blank lacking GSX were also assayed. The amount of GSX in each sample was divided by the number of oocytes to get the intracellular GSX concentration per oocyte. The reduced GSX (GSH) values were calculated from the difference between GSX and GSSG for each oocyte and expressed as pmol/oocyte.
Data Analysis
At least three replicates were used for each treatment. Percentage data were arcsine transformed and analyzed with ANOVA; a Duncan multiplecomparison test was used to locate differences. The software used was the Statistics Package for Social Science (SPSS, Inc.). Data are expressed as the mean 6 SEM, and P , 0.05 is considered to be significant.
RESULTS

Effects of Glucose, Pyruvate, and Lactate on In Vitro Aging of Mouse Oocytes
By supplementing culture media with glucose or its metabolites pyruvate or lactate, we examined whether and how the postovulatory aging oocytes could metabolize glucose to form a basis for the present study. Freshly ovulated COCs and DOs collected 13 h after hCG injection were cultured for 6 h in CZB medium supplemented with glucose, pyruvate, and/or lactate. At the end of culture, oocytes were treated for activation to assess their activation rates. When used individually as a supplement, pyruvate and lactate inhibited aging of both COCs and DOs, but glucose prevented aging of only COCs (Table 1 ). In the presence of either pyruvate, lactate, or both, however, glucose inhibited aging of DOs as well as COCs. The results suggest that whereas the oocyte itself can utilize pyruvate or lactate to prevent aging, it cannot 1112 use glucose unless in the presence of cumulus cells, suggesting that cumulus cells inhibit oocyte aging by producing pyruvate and/or lactate. In addition, few (11.7% 6 2.3%) of the freshly ovulated oocytes were activated when treated for activation immediately after oocyte collection without aging in vitro. When COCs were aged for 12 h in CZB medium supplemented with the regular concentration of glucose (5.56 mM) or pyruvate (0.27 mM), activation rates increased to 38.3% 6 2.0% and 45.3% 6 4.4%, respectively, which are much higher than those of oocytes aged for 6 h in the same medium (5.0% 6 0.7% and 5.9% 6 1.2%) ( Table 1) .
Roles of the PPP and Glycolysis Pathways in Glucose Metabolism in Cumulus Cells
To specify the pathways by which cumulus cells metabolize glucose, freshly ovulated COCs were cultured for 6 h in CZB medium containing glucose and different concentrations of DHEA (the PPP inhibitor) and/or iodoacetate (the glycolysis inhibitor) before being treated for activation. Although oocyte activation rates increased with concentrations of both drugs (Table 2) , the highest activation rate obtained with DHEA was as high as 95%, whereas that obtained with iodoacetate was only 60%. When COCs were cultured in the presence of both iodoacetate and DHEA, however, activation rates increased to over 90%. In other words, when glycolysis was inhibited by iodoacetate, only 60% of the oocytes became aged, mainly because of the lack or shortage of energy supply, whereas the remainder were unaffected, primarily because of protection from harmful oxidation by NADPH produced by the ongoing PPP. When the PPP was inhibited, however, all the oocytes became aged because of oxidative stress as well as energy starvation.
To verify that the PPP prevents oocyte aging chiefly by maintaining the redox status, intraoocyte contents of GSX and the GSH:GSSG ratio were measured after COCs were cultured in the presence of iodoacetate and/or DHEA. Whereas the GSX concentration changed mildly, the GSH:GSSG ratio decreased significantly in oocytes showing a high activation rate in the presence of DHEA (Table 2 ). For example, although showing a similar rate of activation of approximately 60% and similar GSX content, oocytes cultured in the presence of DHEA showed a significantly lower GSH:GSSG ratio than did oocytes cultured with iodoacetate. The results suggest that the PPP prevented oocyte aging mainly by maintaining GSX in a reduced state.
It is well known that PPP generates fructose-6-phosphate and glyceraldehyde-3-phosphate, which are essential for glycolysis. Therefore, we proposed that the glycolysis in cumulus cells might be defective, with pyruvate production depending upon the PPP for intermediate products. To test this hypothesis, freshly collected COCs were cultured for 6 h in CZB medium containing glucose and DHEA (250 lM) in the presence of different concentrations of fructose-6-phosphate before activation was assessed. The results showed that oocyte activation rates decreased significantly with increasing concentrations of fructose-6-phosphate, from 91% at 0 mM to 38% at 20 mM.
Mechanism by Which Pyruvate and Lactate Prevent Oocyte Aging
To study how lactate and pyruvate inhibit aging of oocytes, freshly ovulated DOs were cultured for 6 h in CZB medium containing sodium lactate or pyruvate and the related pathway inhibitors before activation was assayed. When lactate dehydrogenase (LDH) was inhibited with oxamate, rates of oocyte activation increased significantly in the presence of lactate but not pyruvate ( Table 3 ), suggesting that whereas lactate prevents oocyte aging through its LDH-catalyzed oxidation to pyruvate, pyruvate does not depend on its LDHcatalyzed reduction to lactate. When mitochondrial electron transport was inhibited with rotenone, oocyte activation rates increased to 90% in the presence of lactate but only to 50% in the presence of pyruvate. This suggested that whereas lactate inhibited oocyte aging mainly by producing NADH (through its oxidation to pyruvate), which would then be converted into ATP through mitochondrial electron transport, pyruvate did not rely solely on electron transport for its inhibition of oocyte aging. However, when monocarboxylate transfer into the cell or mitochondria was inhibited with 4-CIN, an inhibitor of monocarboxylate transporters (MCTs), oocyte activation increased to the highest level in the presence of both pyruvate and lactate. The results suggest that the inhibition of oocyte aging by both pyruvate and lactate involves mitochondrial electron transport and that) MCTs are active on the plasma membrane and/or mitochondria of the aging oocyte.
PPP and Glycolysis in Cumulus Cells Prevented Oocyte Aging Mainly by Producing Pyruvate
Freshly ovulated COCs were cultured for 6 h in glucosecontaining CZB medium supplemented with iodoacetate, DHEA, or 4-CIN with or without pyruvate. In the presence of a low pyruvate level (0.15 mM), the activation rate of oocytes decreased to the lowest level when glycolysis was inhibited with iodoacetate, but the rate showed only a mild decrease (to 60%) when the PPP was blocked with DHEA, likely because of a lack of NADPH (Table 4 ). In the presence of a higher level (0.27 mM) of pyruvate, however, the activation rate of oocytes decreased to the lowest level whether glycolysis or the PPP was inhibited. The activation rate of the COCs cultured in glucose-containing medium increased to the highest level when pyruvate transfer into mitochondria was inhibited with 4-CIN. The results suggested that 1) the PPP and glycolysis in cumulus cells prevented oocyte aging by producing pyruvate; 2) pyruvate inhibited oocyte aging by its metabolism inside the mitochondrion; 3) a high level of pyruvate inhibited oocyte aging by regulating both the intracellular redox status and energy supply, but a low level of pyruvate provided only energy supply; and 4) the possible toxic effect of iodoacetate and DHEA, which might facilitate aging of oocytes, could be excluded.
Interactive Effects Between Energy Supply and GSX Synthesis on Oocyte Aging
To differentiate between the effects of energy production and redox potential on oocyte aging, freshly ovulated COCs were cultured for 6 h in CZB medium with or without pyruvate and with or without cysteamine and cystine. At the end of culture, oocytes were either treated for activation or assayed for intraoocyte GSX levels. Without cysteamine and cystine, rates of oocyte activation increased from 16% to 60% as the pyruvate concentration decreased from 0.27 to 0.15 mM (Tables 5 and 6 ). In the presence of 0.15 mM pyruvate, addition of cysteamine and cystine increased GSX levels and the GSH:GSSG ratio but inhibited aging of oocytes significantly. When buthionine sulfoximine (BSO) was included in the culture medium with 0.15 mM pyruvate, however, rates of oocyte activation increased to a level as high as that in oocytes aged without cysteamine and cystine supplementation. In the presence of 0.27 mM pyruvate, oocyte aging was inhibited without cysteamine and cystine, and the GSH:GSSG ratio increased significantly. The GSX level, however, did not change. Addition of BSO showed no effect on activation of oocytes aged in the presence of either 0.27 mM pyruvate or glucose. In the absence of energy supply, however, supplementation of thiol compounds showed neither an effect on aging nor an effect on GSX synthesis of oocytes. The results suggest that oocytes synthesize GSX after ovulation in the presence of both energy supply and cysteamine and cystine and that pyruvate inhibits oocyte aging by regulating both the intracellular redox status and energy supply when used at a higher concentration but regulates only energy supply when used at a lower concentration.
DISCUSSION
The most early and prominent manifestations of postovulatory aged oocytes include an increased susceptibility to activating stimuli [34, 35] and decreased maturation-promoting factor (MPF) activity [36] . According to Xu et al. [36] , spontaneous activation was detected in mouse oocytes as early as 4 h postovulation, with a 20% to 25% decrease in the activities of MPF and mitogen-activated protein kinases and with 3% of eggs undergoing both anaphase onset and a partial loss of cortical granules. By measuring activation rates in response to ethanol and 6-DMAP as well as the MPF activity, both our previous studies [25, 27] and the present one indicated that whereas freshly ovulated mouse COCs showed a high (100%) MPF activity but a low (;15%) activation rate, the MPF activity decreased, but the rates of activation increased, 1114 significantly after these oocytes were cultured for 6 h in regular CZB medium or in modified CZB medium without any energy substrate. Rates of fertilization and blastulation also decreased significantly after oocytes were aged for 6 h in regular CZB medium [27] . After oocytes were aged for 12 h in regular CZB medium, rates of fertilization and blastulation decreased further, and other aging manifestations, such as decrease in antiapoptotic protein BCL2 and loss of cortical granules, became obvious [27] . Similar but more obvious changes were observed during oocyte aging in vivo for the same periods of time [27] . In summary, oocyte postovulatory aging is a continuous process starting soon after ovulation, with early spontaneous activation alterations that provide a likely cytological and biochemical basis for the more deleterious aging changes seen over time that result in reduction or total loss of oocyte developmental potential or viability. The reason for us to use a 6-h incubation instead of a longer incubation model in the present study was that oocyte activation rates increased to over 40% by 12 h of incubation with physiological levels of glucose or pyruvate, indicating that severe aging changes had occurred by this time, which would make it more difficult to determine the effect of those treatments aimed at accelerating the aging process. On the basis of our previous results, the present study has examined the effect and mechanism of glucose metabolism on the postovulatory aging of mouse oocytes. The present results suggest that whereas the oocyte itself could utilize pyruvate or lactate to prevent aging, it could not use glucose unless in the presence of cumulus cells. Glucose metabolism in cumulus cells prevented oocyte aging by producing pyruvate and NADPH through glycolysis and the PPP, but the glycolysis in these cells might be defective, with pyruvate production relying on the PPP for intermediate products. Whereas lactate prevented oocyte aging through its LDH-catalyzed oxidation to pyruvate, pyruvate inhibited oocyte aging by its intramitochondrial metabolism. However, both lactate and pyruvate required mitochondrial electron transport to prevent oocyte aging. Measurements of intraoocyte GSX and supplementation of thiols to the aging medium indicated that the inhibition of oocyte aging by both the PPP and pyruvate involved regulation of the intracellular redox status. It was concluded that glucose metabolism in cumulus cells prevented oocyte postovulatory aging by maintaining the intraoocyte redox potential as well as energy supply (Fig. 1) .
Our assay for H1 kinase activities demonstrated that the activity of MPF decreased significantly with increasing activation rates after oocyte aging in the presence of iodoacetate and/or DHEA (data not shown). MPF is a heterodimer formed of cell division cycle 2 homolog A (CDC2A) protein kinase and cyclin B1/B2, and without cyclin B, the CDC2A kinase will not function [37, 38] . It has been shown that the high activity of MPF in oocytes arrested at the metaphase II stage is maintained through a continuous equilibrium between synthesis and degradation of cyclin B [39] . Inhibition of protein synthesis through treatment with cycloheximide resulted in activation of mouse metaphase II oocytes, as assessed by emission of the second polar body and formation of a pronucleus [40] [41] [42] . It was subsequently confirmed that a concomitant decrease in CDC2A/cyclin B kinase activity occurred with the cycloheximide-induced oocyte activation [43] . Kim and Schuetz [44] reported that protein synthesis was markedly inhibited when mouse oocytes were cultured in the pyruvate-deficient medium. It is therefore postulated that the energy insufficiency-induced oocyte activation occurs by affecting the metabolism of oocytes and, hence, inhibiting the synthesis of proteins, such as cyclin B, which results in a decrease in the MPF activity.
In the present study, supplementing the aging medium with cysteamine and cystine increased both the intraoocyte GSX content and the ratio of GSH to GSSG but prevented aging of oocytes as long as they were in the presence of pyruvate. However, addition of BSO, the inhibitor of gamma-glutamylcysteine synthetase, completely counteracted the beneficial effect by cysteamine and cystine in the presence of a low level of pyruvate. Our previous study also showed that pyruvate supplementation to aging medium increased the intracellular concentration of reduced GSX and the level of the antiapoptotic BCL2 proteins in aged mouse oocytes [27] . Furthermore, Boerjan and de Boer [45] reported that the level of GSH was twofold lower in mouse oocytes aged postovulation for 12 h than in the unaged oocytes. It is known that cells generate reactive oxygen species (ROS) as by-products through normal metabolic activities [46, 47] . The increased intracellular ROS has been suggested to induce DNA fragmentation, plasma membrane damage, and ultimately, cell death [48] . ROSinduced apoptosis has also been observed in mammalian oocytes [49, 50] . Furthermore, it has been demonstrated that 
GLUCOSE METABOLISM IN AGING OOCYTES
pyruvate prevents ROS-induced apoptosis in various types of somatic cells [51] [52] [53] [54] [55] by maintaining the level of GSH [53] , increasing the ratio of antiapoptotic molecules BCL2 or BCL2L1 (BCL-Xl) to proapoptotic molecule BAX [53, 54] , and inhibiting the activation of caspase-3 [53, 55, 56] . It is known that both steps in the synthesis of GSX (addition of glutamate and cysteine and the addition of glycine) are dependent on ATP [57] . Once synthesized, GSX cycles between the GSH and the GSSG form through the actions of GSX reductase and GSX peroxidase. The peroxidase transfers electrons from GSH to oxidized molecules within the cytoplasm, minimizing the actions of various oxidative stressors and resulting in the production of GSSG [58] . The cellular pool of GSH is maintained by reduction of GSSG to GSH by GSX reductase as well as further GSH synthesis. The reduction of GSSG requires NADPH, a product from both PPP and the pyruvate metabolism via tricarboxylic acid (TCA) (Fig.  1) . Therefore, intraoocyte concentrations of GSH, and the many processes affected by GSH, are tightly linked to glucose metabolism of the oocyte. Blocking glycolytic activity within oocytes does not influence meiotic maturation of mouse oocytes [16] , but the use of PPP stimulators leads to a dose-dependent increase in germinal vesicle breakdown with increased glucose consumption [24, 59] . Although such data indicate that involvement of glucose in oocyte meiotic regulation is via PPP rather than glycolysis, the mechanism involved is not clear. According to Herrick et al. [60] , it is possible that increased activity of the PPP is one of the initial stimuli for the resumption of meiosis, whereas increased glycolysis is a result of the meiotic progression. In fact, glycolysis has been found to increase coincidently with oocyte maturation in mice, cattle, and cats [15, 59, 61, 62] . In the present study, inhibition of glycolysis promoted aging in 60% of the mouse oocytes, but blocking the PPP induced aging in 95% of the oocytes. The results suggest that whereas PPP was still functioning after inhibition of glycolysis, the glycolysis was completely inactivated after inhibition of the PPP. Furthermore, activities of both glycolysis and the PPP decreased significantly when pig oocytes were treated with the PPP-inhibitor diphenyleneiodonium (DPI) during in vitro maturation [60] . To explain the interactions between the PPP and glycolysis in cumulus cells, we proposed that the glycolysis in these cells might be defective, with pyruvate production depending upon the PPP for intermediate products (Fig. 1) . We tested this hypothesis and showed that fructose-6-phosphate, an intermediate product from the PPP, alleviated oocyte aging significantly when the PPP was totally inhibited with DHEA. In addition, in mice, ribose 5-phosphate produced by the PPP is converted to PRPP, which participates in purine production, via de novo synthesis or the salvage of hypoxanthine and resumption of meiosis [23, 63] . Krisher [64] demonstrated that the inhibitory effects of DPI on the maturation of porcine oocytes could be overcome by supplementing DPI-containing media with PRPP, ribose 5-phosphate, or NADP. Our preliminary observation indicated that whereas supplementing DHEA-containing media with PRPP could not overcome the stimulatory effect of DHEA on oocyte aging, PRPP inhibited aging of mouse oocytes in the presence of 0.15 mM pyruvate (data not shown). Thus, the present results support the idea that in the aging cumulus cells, the PPP may govern glycolysis by providing intermediate substrates for pyruvate production as well as by producing PRPP that blocked the progression of aging.
The present results showed, to our knowledge for the first time, that like pyruvate, lactate could also be utilized by the postovulatory aging oocyte. Our further observation indicated that lactate inhibited oocyte aging mainly by producing NADH through its oxidation to pyruvate and that the NADH would then be converted into ATP through mitochondrial electron transport (Fig. 1) . This is different from the maturing oocytes, which were found to be unable to metabolize lactate unless in the presence of cumulus cells [65, 66] . In the present study, Whereas the oocyte itself can utilize pyruvate or lactate to prevent aging, it cannot use glucose unless in the presence of cumulus cells. Within the cumulus cell, glucose utilization begins with the PPP, where NADPH, glyceraldehyde-3-phosphate, and fructose-6-phosphate are produced. The glyceraldehyde-3-phosphate and fructose-6-phosphate are then used by glycolysis to produce pyruvate. Pyruvate in medium enters the oocyte and is oxidized by the TCA cycle within the ovum mitochondrion (dotted line box) to generate FADH 2 , NADH, NADPH, and GTP. Lactate in medium directly enters the oocyte and produces NADH via LDH-catalyzed oxidation to pyruvate. Cysteine produced from the reduction of cystine by cysteamine in medium enters the oocyte and participates in the production of GSH, a process involving energy supply. Whereas NADPH from both the PPP and the TCA cycle reduces the GSSG, overcoming the oxidizing effect of ROS, NADH produced by the TCA cycle and lactate oxidation generates ATP through electron transfer in the respiratory chain.
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when monocarboxylate transfer into the oocyte or mitochondria was inhibited with 4-CIN, oocyte activation increased to the highest level in the presence of either pyruvate, lactate, or glucose. This suggested that as in other cell types [67, 68] , transportation of lactate and pyruvate across the plasma membrane and into mitochondria was also dependent on the MCTs in the aging oocyte. Furthermore, the present study showed that unlike lactate, pyruvate did not rely solely on electron transport for its inhibition of oocyte aging. It is known that in addition to FADH 2 and NADH that can go into the respiratory chain to generate ATP, pyruvate can also produce, via TCA, NADPH and GTP, which can then be converted into ATP (Fig. 1) . In addition, the highest activation rate obtained in the present study was less than 60% when LDH was inhibited with oxamate, suggesting that the LDH activity in aging oocytes could not be inhibited completely using this drug. Oxamate is a differential inhibitor of LDH isoenzymes; its action on lactate dehydrogenase 1 (LD1; H4) is greater than that on lactate dehydrogenase 5 (LD5; M4) [69] . Thus, under the same conditions, the LDH activity of a human heart extract was inhibited by approximately 50%, whereas that of a human liver extract was only reduced by approximately 20%. However, whereas both pyruvate and lactate were capable of inhibiting the activation of oocytes when added alone, a significant fraction of COCs became activated in the presence of both pyruvate and lactate in the absence of glucose in the present study. Increasing the lactate concentration in the medium has been found to significantly reduce pyruvate uptake of mouse embryos [70] . Our experiments conducted under the same conditions as the present study (data not shown) also indicated that pyruvate and lactate each interfered with the other's utilization by cumulus cells in a concentrationdependent manner. However, the mechanism by which pyruvate interferes with the utilization of lactate needs further investigation.
In summary, the present results suggest that the postovulatory aging oocyte model can be successfully used for study of glucose metabolism of oocytes and that glucose metabolism plays a crucial role in preventing oocyte aging after ovulation. The advantages of the postovulatory aging oocyte model for study of intermediary metabolism include that it does not involve the drugs used for control of meiotic resumption as in the maturing oocyte model and that the effect of metabolism manipulation can be easily and accurately evaluated by observing the aging status (activation rate) of oocytes. The data obtained not only have contributed to our understanding of the glucose metabolism in oocytes but also have provided important information that can potentially be used for the formulation of more optimal media in clinical assisted reproductive technology.
